我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

冠状动脉支架内血栓形成机制与对策(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第1期
页码:
104-107
栏目:
综述
出版日期:
2008-01-20

文章信息/Info

Title:
-
作者:
李宏松 综述刘建平 审校
上海交通大学医学院附属仁济医院心内科,上海 200001
Author(s):
-
关键词:
支架内血栓机制预防治疗
Keywords:
-
分类号:
R543.3
DOI:
-
文献标识码:
A
摘要:
冠状动脉支架介入治疗已有越来越多的选择,但支架内血栓形成仍是临床尚未能最终解决的问题。本文就目前冠状动脉支架内血栓形成机制与对策的研究进展作一综述。
Abstract:
-

参考文献/References

[1] Ong AT,Hoye A,Aoki J,et al.Thirtyday incidence and sixmonth clinical outcome of thrombotic stent occlusion after baremetal,sirolimus,or paclitaxel stent implantation[J].J Am Coll Cardiol,2005,45(6):947-953.

[2] Iakovou I,Schmidt T,Bonizzoni E,et al. 1ncidenee,predictors, and outcome of thrombosis after successful implantation of drugeluting stents[J].JAMA,2005,293(17):2126-2130.

[3] Rodriguez AE, Mieres J, FernandezPereira C,et al.Coronary stent thrombosis in the current drugeluting stent era: insights from the ERACI III trial[J].J Am Coll Cardiol,2006 ,47(1):205-207.

[4] BalaguerMalfagón JR, PomarDomingo F, VilarHerrero JV,et al.Stent thrombosis in the modern era: incidence, outcome and predictive factors[J].Rev Esp Cardiol,2006,59(8):842-845.

[5] Williams DO,Abbott JD, Kip KE,et al.Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drugeluting stents: report of the DEScover Registry[J].Circulation,2006,114(20):2154-2162.

[6] Carter AJ, Aggarwal M, Kopia GA,et al. Longterm effects of polymerbased, slowrelease, sirolimuseluting stents in a porcine coronary model[J].Cardiovasc Res, 2004, 63(4): 617-624.

[7] Joner M,Finn AV, Farb A,et al. Pathology of drugeluting stents in humans: delayed healing and late thrombotic risk[J].J Am Coll Cardiol,2006,48(1):193-202.

[8] Tamura A ,Watanabe T, Nagase K,et al.Circadian Variation in Symptomatic Subacute Stent Thrombosis After Bare Metal Coronary Stent Implantation[J].Am J Cardiol,2006,97(2):195-197.

[9] Wenaweser P, DrfflerMelly J, Imboden K,et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy[J].J Am Coll Cardiol,2005,45(11): 1748-1752.

[10]Nguyen TA,Diodati JG,Pharand C. Resistance to clopidogrel:a review of the evidence[J].J Am Coll Cardiol,2005,45(8):1157-1164.

[11]Fuchigami S, Oshima S, Hokimoto S,et al. Subacute thrombosis after coronary stenting occurring with resistance to ticlopidine[J].Intern Med,2006,45(10):675-678.

[12]Virmani R,Guagliumi G ,Farb A,et al.Localized hypersensitivity and late coronary thrombosis secondarv to a sirolimuseluting stent: should we be cautious?[J].Circulatious,2004,109(6):701-705.

[13]Brichon PY, Boitet P, Dujon A,et al. Perioperative instent thrombosis after lung resection performed within 3 months of coronary stenting[J]. Eur J Cardiothorac Surg.2006, 30(5):793-796.

[14]Lee SW, Park SW, Hong MK ,et al.Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis[J].J Am Coll Cardiol,2005 ,46(10): 1833-1837.

备注/Memo

备注/Memo:
收稿日期:2006-11-28.通讯作者:刘建平,主任医师,主要从事冠心病的介入治疗及心律失常的诊治Email:IPL@fmmu.com 作者简介:李宏松,主治医师,硕士生 Email:lys_hs@126.com.
更新日期/Last Update: